Description
Recombinant monoclonal antibody to CD8 beta. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma YTS 156.7.7.
Target
CD8 beta
Target Alias Names
Lyt-3, T-cell surface glycoprotein CD8 beta chain, Lymphocyte antigen 3, T-cell membrane glycoprotein Ly-3, T-cell surface glycoprotein Lyt-3, CD8b, Cd8b, Cd8b1, Ly-3, Lyt-3, Lyt3
Isotype/Mimetic
IgG2b
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression